Was There a Patient in Your Clinic Today Who Was Distressed?

Authors: Jimmie C. Holland MD, Mark Lazenby PhD, APRN and Matthew J. Loscalzo LCSW
View More View Less
Restricted access

Jimmie C. Holland, MD, recognized internationally as the founder of the subspecialty of psychooncology, is Attending Psychiatrist and holds the first endowed chair in Psychiatric Oncology, the Wayne E. Chapman Chair at Memorial Sloan Kettering Cancer Center. She is Professor of Psychiatry at Weill Medical College of Cornell University. She began the first full-time Psychiatric Service in a cancer hospital in 1977 at Memorial Sloan Kettering Cancer Center, and in 1996 she became the first woman Chair of a clinical department at Memorial. Dr. Holland was PI of the first research training grant in psycho-oncology which has continued uninterrupted for 34 years.

Dr. Holland established the first committee studying psychological and quality of life issues in a cooperative group, the Cancer Leukemia Group B. In the 1980s she became the Founding President of the International Psycho-oncology Society (1984) and of the American Psychosocial Oncology Society (1986). She has been senior editor of multiple textbooks, and in 1992, she started the first international journal in the field, Psycho-Oncology, and continues as co-editor. Dr. Holland has chaired the NCCN Panel on Management of Distress since its beginning in 1997. She was elected to the Institute of Medicine in 1995 and served on the panel that established a new standard of quality cancer care which demands that the psychosocial domain be integrated into routine cancer care. Dr. Holland has received numerous awards from the ACS, ASCO, AACR, and other national and international associations.

Mark Lazenby, PhD, APRN, is Associate Professor of Nursing at Yale. He holds joint appointments on the Divinity and Middle East Studies faculties. His work centers on bringing whole-patient care to underserved populations. He and colleagues in Botswana are working to put into place routine distress and symptom screening among patients with cancer in Botswana, and he is developing a spiritually sensitive palliative care intervention for Muslims who are in treatment for advanced cancer.

The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of NCCN.

Matthew J. Loscalzo, LCSW, is the Liliane Elkins Professor in Supportive Care Programs in the Department of Supportive Care Medicine and Professor in Department of Population Sciences. He is also the Executive Director of the Department of Supportive Care Medicine and the Administrative Director of the Sheri & Les Biller Patient and Family Resource Center at the City of Hope-National Medical Center.

Mr. Loscalzo has held leadership positions at several major academic cancer centers. In, October 2014, he was recognized for a lifetime achievement award in clinical care by the International Psycho-Oncology Society. In August 2015, he received the Jimmie Holland Life Time Leadership Award from the American Psychosocial Oncology Society.

Mr. Loscalzo has more than 35 years' experience caring for cancer patients and families and is recognized internationally as a pioneer in the psychosocial aspects of cancer. Professor Loscalzo was the President of the American Psychosocial Oncology Society and the Association of Oncology Social Workers.

He is the PI on two 5 year NIH R25E training grants and a site PI for a new third R25E. He is also on the editorial boards or a reviewer for a number of professional journals and has over 100 publications. His clinical interests are gender medicine; strengths based approaches to psychotherapies, problem-based distress screening, and the creation of supportive care programs.

  • 1.

    Weisman AD, Worden JW. The existential plight in cancer: significance of the first 100 days. Intl J Psychiatry Med 1976;7:115.

  • 2.

    Holland JC. Preliminary guidelines for the treatment of distress. Oncology (Williston Park) 1997;11:109114; discussion, 115–117.

  • 3.

    Holland JC, Jacobsen PB, Anderson B. NCCN Clinical Practice Guidelines in Oncology: Distress Management. Version 2.2015. Available at NCCN.org. Accessed August 12, 2015.

    • Search Google Scholar
    • Export Citation
  • 4.

    Adler NE, Page AE, eds. Cancer care for the whole patient. Washington DC: National Academies Press; 2008.

  • 5.

    American College of Surgeons Commission on Cancer. Cancer Program Standards 2012: Ensuring Patient-Centered Care. Available at https://www.facs.org/~/media/files/quality%20programs/cancer/coc/programstandards2012.ashx. Accessed August 12, 2015.

    • Search Google Scholar
    • Export Citation
  • 6.

    Lazenby M, Ercolano E, Grant M. Supporting commission on cancer-mandated psychosocial distress screening with implementation strategies. J Oncol Pract 2015;11:e413420.

    • Search Google Scholar
    • Export Citation
  • 7.

    Penman D, Holland JC, Bahna G. Informed consent for investigational chemotherapy. Patients' and physicians' perceptions. J Clin Oncol 1984;2:849855.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 99 82 15
PDF Downloads 26 22 1
EPUB Downloads 0 0 0